NCT02469402View on ClinicalTrials.gov

Nutritive Efficacy and Safety of a Modified Infant Formula With a Reduced Protein Content and Improved Protein Quality

NACompletedINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2016

Conditions

Overweight

Interventions

DIETARY_SUPPLEMENT

Standard infant formula

DIETARY_SUPPLEMENT

Protein reduced alpha-lactalbumin formula, with higher levels of alpha-lactalbumin

Trial Locations (1)

13589

Evangelisches Waldkrankenhaus Spandau, Berlin

All Listed Sponsors

collaborator

Humana Inc.

INDUSTRY

lead

Waldkrankenhaus Protestant Hospital, Spandau

OTHER

NCT02469402 - Nutritive Efficacy and Safety of a Modified Infant Formula With a Reduced Protein Content and Improved Protein Quality | Biotech Hunter | Biotech Hunter